Update in Hospital Medicine
Authors: Franklin A. Michota
Journal: Annals of Internal Medicine (2000)

Updates from the Annual Session7 March 2000Update in Hospital MedicineFranklin A. Michota Jr, MDFranklin A. Michota Jr, MDFrom Cleveland Clinic Foundation, Cleveland, Ohio.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-132-5-200003070-00008 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail The boundaries of hospital medicine are not defined by specific organs and their associated diseases but rather by the severity of the patient's condition, the subsequent risk for morbidity and death, and the intensity and monitoring of treatment necessary to provide care. Four content areas relevant to the care of hospitalized patients are the focus of this Update: nosocomial illness, community-acquired pneumonia, venous thromboembolic disease, and prognostic variables.Nosocomial IllnessPhysicians take an oath to do no harm, but the hospital environment itself carries its own risk. This disparity is addressed in the following section through a discussion of antibiotic ...References1. Moellering RC. Emergence of Enterococcus as a significant pathogen. Clin Infect Dis. 1992;14:1173-6. CrossrefMedlineGoogle Scholar2. Noskin GA, Peterson LR, Warren JR. Enterococcus faecium and Enterococcus faecalis bacteremia: acquisition and outcome. Clin Infect Dis. 1995;20:296-301. CrossrefMedlineGoogle Scholar3. Gullberg RM, Homann SR, Phair JP. Enterococcal bacteremia: analysis of 75 episodes. Rev Infect Dis. 1989;11:74-85. CrossrefMedlineGoogle Scholar4. Rahal JJ, Urban C, Horn D, Freeman K, Segal-Maurer S, Maurer J, et al . Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella . JAMA. 1998;280:1233-7. CrossrefMedlineGoogle Scholar5. Greenberger NJ. Update in gastroenterology. Ann Intern Med. 1999;131:445-52. LinkGoogle Scholar6. Patterson JA, Bennett RG. Prevention and treatment of pressure sores. J Am Geriatr Soc. 1995;43:919-27. CrossrefMedlineGoogle Scholar7. AGS Clinical Practice Committee. Pressure ulcers in adults: prediction and prevention. J Am Geriatr Soc. 1996;44:1118-9. CrossrefMedlineGoogle Scholar8. The Role of the Hospital: Technical Report Series No. 425. Geneva, Switzerland: World Health Organization; 1966. Google Scholar9. Rawlins M, Thompson J. Mechanisms of adverse drug reactions. In: Davies DM, ed. Textbook of Adverse Drug Reactions. 4th ed. Oxford, England: Oxford Univ Pr; 1991. Google Scholar10. Karnik AM. Update in pulmonary diseases. Ann Intern Med. 1999;131:596-604. LinkGoogle Scholar11. Fine MJ, Hough LJ, Medsger AR, Li YH, Ricci EM, Singer DE, et al . The hospital admission decision for patients with community-acquired pneumonia. Results from the pneumonia Patient Outcomes Research Team (PORT) cohort study. Arch Intern Med. 1997;157:36-44. CrossrefMedlineGoogle Scholar12. Niederman MS, Bass JB, Campbell GD, Fein AM, Grossman RF, Mandell LA, et al . Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association. Am Rev Respir Dis. 1993;148:1418-26. CrossrefMedlineGoogle Scholar13. The British Thoracic Society. Guidelines for the management of community-acquired pneumonia in adults admitted to hospital. Br J Hosp Med. 1993;49:346-50. MedlineGoogle Scholar14. Jolley AE, Davies AJ, Mcleod DT. Audit of the use of erythromycin in the treatment of community-acquired lower respiratory infection. Respir Med. 1992;86:503-5. CrossrefMedlineGoogle Scholar15. Garibaldi RA. Epidemiology of community-acquired respiratory tract infections in adults. Incidence, etiology, and impact. Am J Med. 1985;78:32-7. CrossrefMedlineGoogle Scholar16. Medicare and Medicaid statistical supplement, 1997. Health Care Financ Rev. 1997; 18(Suppl):73. Google Scholar17. Lave JR, Fine MJ, Sankey SS, Hanusa BH, Weissfeld LA, Kapoor WN. Hospitalized pneumonia. Outcomes, treatment patterns, and costs in urban and rural areas. J Gen Intern Med. 1996;11:415-21. CrossrefMedlineGoogle Scholar18. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al . A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336:243-50. CrossrefMedlineGoogle Scholar19. Altkorn D, Roach K, Stern S, Levinson W. Update in general internal medicine. Ann Intern Med. 1999;131:199-206. LinkGoogle Scholar20. Guntupalli KK, Fromm JE. Update in critical care medicine. Ann Intern Med. 1999;131:288-95. Google Scholar21. Hyers TM, Hull RD, Weg JG. Antithrombotic therapy for venous thromboembolic disease. Chest. 1995;108 Suppl 335-51S. CrossrefMedlineGoogle Scholar22. Leizorovicz A. Comparison of the efficacy and safety of low-molecular-weight heparins and unfractionated heparin in the initial treatment of deep venous thrombosis. An updated meta-analysis. Drugs. 1996;52 Suppl 7 30-7. CrossrefMedlineGoogle Scholar23. Becker DM, Philbrick JT, Selby JB. Inferior vena cava filters. Indications, safety, effectiveness. Arch Intern Med. 1992;152:1985-94. CrossrefMedlineGoogle Scholar24. Hirsh J, Hoak J. Management of deep vein thrombosis and pulmonary embolism. A statement for healthcare professionals. Council on Thrombosis (in consultation with the Council on Cardiovascular Radiology), American Heart Association. Circulation. 1996;93:2212-45. CrossrefMedlineGoogle Scholar25. Magnant JG, Walsh DB, Juravsky LI, Cronenwett JL. Current use of inferior vena cava filters. J Vasc Surg. 1992;16:701-6. CrossrefMedlineGoogle Scholar26. Koopman MM, Prandoni P, Piovella F, Ockelford PA, Brandjes DP, van der Meer J, et al . Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. N Engl J Med. 1996;334:682-7. CrossrefMedlineGoogle Scholar27. Levine M, Gent M, Hirsh J, Leclerc J, Anderson D, Weitz J, et al . A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med. 1996;334:677-81. CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAuthors: Franklin A. MichotaJr, MDAffiliations: From Cleveland Clinic Foundation, Cleveland, Ohio.Corresponding Author: Franklin A. Michota Jr., MD, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoOptimal Acid Suppression Therapy in Critically Ill Patients Darrell S. Pardi Metrics Cited byOptimal Acid Suppression Therapy in Critically Ill PatientsDarrell S. Pardi, MD 7 March 2000Volume 132, Issue 5Page: 384-390KeywordsAdverse reactionsAntibioticsDeep vein thrombosisGastroenterology and hepatologyHemorrhageLow molecular weight heparinOutpatientsPneumoniaPressure ulcersVancomycin resistant enterococcus ePublished: 15 August 2000 Issue Published: 7 March 2000 Copyright & PermissionsCopyright © 2000 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...